The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in Inflammation
Hirsch, E., Katanaev, V. L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., & Wymann, M. P. (2000) · Science · doi:10.1126/science.287.5455.1049 · Cited by 1,209
Function of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A. J., Stanford, W. L., Bolon, B., Wakeham, A., Itie, A., Bouchard, D., Kozieradzki, I., et al. (2000) · Science · doi:10.1126/science.287.5455.1040 · Cited by 1,031
Current development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
Stallone, G., Schena, A., Infante, B., Di Paolo, S., Loverre, A., Maggio, G., Ranieri, E., Gesualdo, L., Schena, F. P., & Grandaliano, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042831 · Cited by 990
Advances in protein kinase B signalling: AKTion on multiple fronts
Brazil, D. P., Yang, Z.-Z., & Hemmings, B. A. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.006 · Cited by 830
PI3K in lymphocyte development, differentiation and activation
Okkenhaug, K., & Vanhaesebroeck, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1056 · Cited by 810
Guha, M., & Mackman, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203298200 · Cited by 799
Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis
Camps, M., Rückle, T., Ji, H., Ardissone, V., Rintelen, F., Shaw, J., Ferrandi, C., Chabert, C., Gillieron, C., Françon, B., et al. (2005) · Nature Medicine · doi:10.1038/nm1284 · Cited by 750
Sekulić, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., & Abraham, R. T. (2000) · PubMed · Cited by 710
Control of p70 S6 kinase by kinase activity of FRAP in vivo
Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Bum Shin, T., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705
Rheb promotes cell growth as a component of the insulin/TOR signalling network
Saucedo, L. J., Gao, X., Chiarelli, D. A., Li, L., Pan, D., & Edgar, B. A. (2003) · Nature Cell Biology · doi:10.1038/ncb996 · Cited by 658
Bischoff, S. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2018 · Cited by 620
TOR signalling in bugs, brain and brawn
Jacinto, E., & Hall, M. N. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1018 · Cited by 565
Targeting phosphoinositide 3-kinase—Moving towards therapy
Marone, R., Cmiljanovic, V., Giese, B., & Wymann, M. P. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.10.003 · Cited by 548
Yang, Q., & Guan, K.-L. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 535
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila
Stocker, H., Radimerski, T., Schindelholz, B., Wittwer, F., Belawat, P., Daram, P., Breuer, S., Thomas, G., & Hafen, E. (2003) · Nature Cell Biology · doi:10.1038/ncb995 · Cited by 530
PI3K-mediated negative feedback regulation of IL-12 production in DCs
Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., & Koyasu, S. (2002) · Nature Immunology · doi:10.1038/ni825 · Cited by 529
The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2
Huang, J., Dibble, C. C., Matsuzaki, M., & Manning, B. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00289-08 · Cited by 511
The role of PI3K in immune cells
Koyasu, S. (2003) · Nature Immunology · doi:10.1038/ni0403-313 · Cited by 487
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Mocellin, S. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00009-1 · Cited by 463
Essential role for the p110δ phosphoinositide 3-kinase in the allergic response
Ali, K., Bilancio, A., Thomas, M., Pearce, W., Gilfillan, A. M., Tkaczyk, C., Kuehn, N., Gray, A., Giddings, J., Peskett, E., et al. (2004) · Nature · doi:10.1038/nature02991 · Cited by 387
P hosphoinositide 3-K inase : Diverse Roles in Immune Cell Activation
Deane, J. A., & Fruman, D. A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104721 · Cited by 346
Knall, C., Worthen, G. S., & Johnson, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3052 · Cited by 321
Translational control of the innate immune response through IRF-7
Colina, R., Costa-Mattioli, M., Dowling, R. J. O., Jaramillo, M., Tai, L.-H., Breitbach, C. J., Martineau, Y., Larsson, O., Rong, L., Svitkin, Y. V., et al. (2008) · Nature · doi:10.1038/nature06730 · Cited by 316
PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus
Barber, D. F., Bartolomé, A., Hernandez, C., Flores, J. M., Redondo, C., Fernandez-Arias, C., Camps, M., Rückle, T., Schwarz, M. K., Rodríguez, S., et al. (2005) · Nature Medicine · doi:10.1038/nm1291 · Cited by 310
Dissociation of raptor from mTOR is a mechanism of rapamycin‐induced inhibition of mTOR function
Oshiro, N., Yoshino, K., Hidayat, S., Tokunaga, C., Hara, K., Eguchi, S., Avruch, J., & Yonezawa, K. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00727.x · Cited by 308
SIROLIMUS-ASSOCIATED PULMONARY TOXICITY
Pham, P.-T. T., Pham, P.-C. T., Danovitch, G. M., Ross, D. J., Gritsch, H. A., Kendrick, E. A., Singer, J., Shah, T., & Wilkinson, A. H. (2004) · Transplantation · doi:10.1097/01.tp.0000118413.92211.b6 · Cited by 298
Martin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J., & Michalek, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.717 · Cited by 257
IL-10, an inflammatory/inhibitory cytokine, but not always
Conti, P., Kempuraj, D., Kandere, K., Gioacchino, M. D., Barbacane, R. C., Castellani, M. L., Felaco, M., Boucher, W., Letourneau, R., & Theoharides, T. C. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00002-6 · Cited by 235
Guiducci, C., Ghirelli, C., Marloie-Provost, M.-A., Matray, T., Coffman, R. L., Liu, Y.-J., Barrat, F. J., & Soumelis, V. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070763 · Cited by 230
Rapamycin: Something Old, Something New, Sometimes Borrowed and Now Renewed
Hartford, C. M., & Ratain, M. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100317 · Cited by 228
Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice
Fukao, T., Yamada, T., Tanabe, M., Terauchi, Y., Ota, T., Takayama, T., Asano, T., Takeuchi, T., Kadowaki, T., Hata, J.-I., et al. (2002) · Nature Immunology · doi:10.1038/ni768 · Cited by 193
Role of Phosphoinositide 3-Kinase in Innate Immunity
Hazeki, K., Nigorikawa, K., & Hazeki, O. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1617 · Cited by 188
Modulation of the Phosphoinositide 3-Kinase Pathway Alters Innate Resistance to Polymicrobial Sepsis
Williams, D. L., Li, C., Ha, T., Ozment-Skelton, T., Kalbfleisch, J. H., Preiszner, J., Brooks, L., Breuel, K., & Schweitzer, J. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.449 · Cited by 175
Woltman, A. M., van der Kooij, S. W., Coffer, P. J., Offringa, R., Daha, M. R., & van Kooten, C. (2003) · Blood · doi:10.1182/blood-2002-06-1688 · Cited by 153
Rosner, M., Hanneder, M., Siegel, N., Valli, A., & Hengstschläger, M. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.01.001 · Cited by 145
Activation and Function of the mTORC1 Pathway in Mast Cells
Kim, M., Kuehn, H. S., Metcalfe, D. D., & Gilfillan, A. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4586 · Cited by 129
Ali, K., Camps, M., Pearce, W. P., Ji, H., Rückle, T., Kuehn, N., Pasquali, C., Chabert, C., Rommel, C., & Vanhaesebroeck, B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2538 · Cited by 125
Aksoy, E., Berghe, W. V., Detienne, S., Amraoui, Z., Fitzgerald, K. A., Haegeman, G., Goldman, M., & Willems, F. (2005) · European Journal of Immunology · doi:10.1002/eji.200425801 · Cited by 125
Gómez-Cambronero, J., Horn, J. M., Paul, C. C., & Baumann, M. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6846 · Cited by 124
Mulay, A. V., Hussain, N., Fergusson, D. A., & Knoll, G. A. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00931.x · Cited by 114
Yang, C., Song, C., Lee, J., Jung, S.-B., Oh, J.-H., Park, J., Kim, H., Park, J., Paik, T.-H., & Jo, E. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00699.x · Cited by 107
Interstitial Pneumonitis Associated with Sirolimus Therapy in Renal-Transplant Recipients
Singer, S. J., Tiernan, R., & Sullivan, E. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432417 · Cited by 103
Rapamycin inhibits GM‐CSF‐induced neutrophil migration
Gómez-Cambronero, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00828-7 · Cited by 97
Thaunat, O., Beaumont, C., Chatenoud, L., Lechaton, S., Mamzer, M., Varet, B. R., Kreis, H., & Morélon, E. (2005) · Transplantation · doi:10.1097/01.tp.0000179106.07382.6a · Cited by 92
Polumuri, S. K., Toshchakov, V. Y., & Vogel, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.236 · Cited by 76
Sirolimus-Induced Pneumonitis: Three Cases and a Review of the Literature
Haydar, A., Denton, M., West, A., Rees, J., & Goldsmith, D. J. A. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6135.2003.00292.x · Cited by 73
Influence of immunosuppressive drugs on dendritic cells
Abe, M., & Thomson, A. W. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00050-9 · Cited by 68
Lindemann, S. W., Yost, C. C., Denis, M. M., McIntyre, T. M., Weyrich, A. S., & Zimmerman, G. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401901101 · Cited by 65
Roles of PI3K in Neutrophil Function
Hannigan, M. O., Huang, C., & Wu, D. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18805-3_6 · Cited by 57
Efficacy of Sirolimus in Treating Tuberous Sclerosis and Lymphangioleiomyomatosis
Paul, E., & Thiele, E. A. (2008) · New England Journal of Medicine · doi:10.1056/nejme0707153 · Cited by 56
KODAMA, T., Hazeki, K., Hazeki, O., Okada, T., & Ui, M. (1999) · Biochemical Journal · doi:10.1042/bj3370201 · Cited by 54
Activated Polymorphonuclear Leukocytes Rapidly Synthesize Retinoic Acid Receptor-α
Yost, C. C., Denis, M. M., Lindemann, S., Rubner, F. J., Marathe, G. K., Buerke, M., McIntyre, T. M., Weyrich, A. S., & Zimmerman, G. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040224 · Cited by 53
Hartman, M. E., O’Connor, J. C., Godbout, J. P., Minor, K. D., Mazzocco, V. R., & Freund, G. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404368200 · Cited by 50
Barcová, M., Speth, C., Kacani, L., Überall, F., Stoiber, H., & Dierich, M. P. (1999) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050815 · Cited by 18
Tsiavou, A., Degiannis, D., Hatziagelaki, E. E., Koniavitou, K., & Raptis, S. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00208-4 · Cited by 13
Cited by
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Martinez-Pomares, L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512231 · Cited by 531
The Role of Macrophage Polarization in Infectious and Inflammatory Diseases
Labonte, A. C., Tosello-Trampont, A.-C., & Hahn, Y. S. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2374 · Cited by 335
Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications
Eleuteri, S., & Fierabracci, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184597 · Cited by 303
Gao, J., Qiu, X., Xi, G., Liu, H., Zhang, F., Lv, T., & Song, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6634 · Cited by 275
Metadata
- Authors
- Weichhart, T., & Säemann, M. D.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 67
- Pages
- iii70-iii74
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2063040754
- Cited by
- 323
- References
- 71
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.